Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.

Hansson O, Janelidze S, Hall S, Magdalinou N, Lees AJ, Andreasson U, Norgren N, Linder J, Forsgren L, Constantinescu R, Zetterberg H, Blennow K; Swedish BioFINDER study.

Neurology. 2017 Mar 7;88(10):930-937. doi: 10.1212/WNL.0000000000003680. Epub 2017 Feb 8.

2.

Serum neurofilament light protein predicts clinical outcome in traumatic brain injury.

Shahim P, Gren M, Liman V, Andreasson U, Norgren N, Tegner Y, Mattsson N, Andreasen N, Öst M, Zetterberg H, Nellgård B, Blennow K.

Sci Rep. 2016 Nov 7;6:36791. doi: 10.1038/srep36791.

3.

Common susceptibility variants are shared between schizophrenia and psoriasis in the Han Chinese population.

Yin X, Wineinger NE, Wang K, Yue W, Norgren N, Wang L, Yao W, Jiang X, Wu B, Cui Y, Shen C, Cheng H, Zhou F, Chen G, Zuo X, Zheng X, Fan X, Wang H, Wang L, Lee J, Lam M, Tai ES, Zhang Z, Huang Q, Sun L, Xu J, Yang S, Wilhelmsen KC, Liu J, Schork NJ, Zhang X.

J Psychiatry Neurosci. 2016 Oct;41(6):413-421.

4.

Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia.

Rohrer JD, Woollacott IO, Dick KM, Brotherhood E, Gordon E, Fellows A, Toombs J, Druyeh R, Cardoso MJ, Ourselin S, Nicholas JM, Norgren N, Mead S, Andreasson U, Blennow K, Schott JM, Fox NC, Warren JD, Zetterberg H.

Neurology. 2016 Sep 27;87(13):1329-36. doi: 10.1212/WNL.0000000000003154. Epub 2016 Aug 31.

5.

Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS.

Bergman J, Dring A, Zetterberg H, Blennow K, Norgren N, Gilthorpe J, Bergenheim T, Svenningsson A.

Neurol Neuroimmunol Neuroinflamm. 2016 Aug 2;3(5):e271. doi: 10.1212/NXI.0000000000000271. eCollection 2016 Oct.

6.

Blood biomarkers indicate mild neuroaxonal injury and increased amyloid β production after transient hypoxia during breath-hold diving.

Gren M, Shahim P, Lautner R, Wilson DH, Andreasson U, Norgren N, Blennow K, Zetterberg H.

Brain Inj. 2016;30(10):1226-30. doi: 10.1080/02699052.2016.1179792. Epub 2016 Jul 7.

PMID:
27389622
7.

Corrigendum to: "Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study" [EBioMedicine 3 (216) 135-140].

Gisslén M, Price RW, Andreasson U, Norgren N, Nilsson S, Hagberg L, Fuchs D, Spudich S, Blennow K, Zetterberg H.

EBioMedicine. 2016 May;7:287-288. doi: 10.1016/j.ebiom.2016.04.021. Epub 2016 Apr 20. No abstract available.

8.

Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa.

Kuhle J, Barro C, Andreasson U, Derfuss T, Lindberg R, Sandelius Å, Liman V, Norgren N, Blennow K, Zetterberg H.

Clin Chem Lab Med. 2016 Oct 1;54(10):1655-61. doi: 10.1515/cclm-2015-1195.

PMID:
27071153
9.

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.

Gisslén M, Price RW, Andreasson U, Norgren N, Nilsson S, Hagberg L, Fuchs D, Spudich S, Blennow K, Zetterberg H.

EBioMedicine. 2015 Nov 22;3:135-140. doi: 10.1016/j.ebiom.2015.11.036. eCollection 2016 Jan. Erratum in: EBioMedicine. 2016 May;7:287-288.

10.

Effect of Docosahexaenoic Acid on a Biomarker of Head Trauma in American Football.

Oliver JM, Jones MT, Kirk KM, Gable DA, Repshas JT, Johnson TA, Andréasson U, Norgren N, Blennow K, Zetterberg H.

Med Sci Sports Exerc. 2016 Jun;48(6):974-82. doi: 10.1249/MSS.0000000000000875.

PMID:
26765633
11.

Serum Neurofilament Light in American Football Athletes over the Course of a Season.

Oliver JM, Jones MT, Kirk KM, Gable DA, Repshas JT, Johnson TA, Andréasson U, Norgren N, Blennow K, Zetterberg H.

J Neurotrauma. 2016 Oct 1;33(19):1784-1789. Epub 2016 Mar 16.

PMID:
26700106
12.

Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction.

Vågberg M, Norgren N, Dring A, Lindqvist T, Birgander R, Zetterberg H, Svenningsson A.

PLoS One. 2015 Aug 28;10(8):e0135886. doi: 10.1371/journal.pone.0135886. eCollection 2015.

13.

CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders.

Herbert MK, Aerts MB, Beenes M, Norgren N, Esselink RA, Bloem BR, Kuiperij HB, Verbeek MM.

Front Neurol. 2015 May 5;6:91. doi: 10.3389/fneur.2015.00091. eCollection 2015.

14.

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.

Lu CH, Macdonald-Wallis C, Gray E, Pearce N, Petzold A, Norgren N, Giovannoni G, Fratta P, Sidle K, Fish M, Orrell R, Howard R, Talbot K, Greensmith L, Kuhle J, Turner MR, Malaspina A.

Neurology. 2015 Jun 2;84(22):2247-57. doi: 10.1212/WNL.0000000000001642. Epub 2015 May 1. Erratum in: Neurology. 2015 Sep 8;85(10):921.

15.

Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.

Disanto G, Adiutori R, Dobson R, Martinelli V, Dalla Costa G, Runia T, Evdoshenko E, Thouvenot E, Trojano M, Norgren N, Teunissen C, Kappos L, Giovannoni G, Kuhle J; International Clinically Isolated Syndrome Study Group.

J Neurol Neurosurg Psychiatry. 2016 Feb;87(2):126-9. doi: 10.1136/jnnp-2014-309690. Epub 2015 Feb 25.

PMID:
25716934
16.

Ancillary investigations to diagnose parkinsonism: a prospective clinical study.

Aerts MB, Esselink RA, Abdo WF, Meijer FJ, Drost G, Norgren N, Janssen MJ, Borm GF, Bloem BR, Verbeek MM.

J Neurol. 2015 Feb;262(2):346-56. doi: 10.1007/s00415-014-7568-4. Epub 2014 Nov 9.

PMID:
25381460
17.

Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome.

Kuhle J, Gaiottino J, Leppert D, Petzold A, Bestwick JP, Malaspina A, Lu CH, Dobson R, Disanto G, Norgren N, Nissim A, Kappos L, Hurlbert J, Yong VW, Giovannoni G, Casha S.

J Neurol Neurosurg Psychiatry. 2015 Mar;86(3):273-9. doi: 10.1136/jnnp-2013-307454. Epub 2014 Jun 16.

PMID:
24935984
18.

Gene expression profile in hereditary transthyretin amyloidosis: differences in targeted and source organs.

Norgren N, Olsson M, Nyström H, Ericzon BG, de Tayrac M, Genin E, Planté-Bordeneuve V, Suhr OB.

Amyloid. 2014 Jun;21(2):113-9. doi: 10.3109/13506129.2014.894908. Epub 2014 Mar 7.

19.

The impact of pre-analytical variables on the stability of neurofilament proteins in CSF, determined by a novel validated SinglePlex Luminex assay and ELISA.

Koel-Simmelink MJ, Vennegoor A, Killestein J, Blankenstein MA, Norgren N, Korth C, Teunissen CE.

J Immunol Methods. 2014 Jan 15;402(1-2):43-9. doi: 10.1016/j.jim.2013.11.008. Epub 2013 Nov 22.

PMID:
24275679
20.

Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.

Gaiottino J, Norgren N, Dobson R, Topping J, Nissim A, Malaspina A, Bestwick JP, Monsch AU, Regeniter A, Lindberg RL, Kappos L, Leppert D, Petzold A, Giovannoni G, Kuhle J.

PLoS One. 2013 Sep 20;8(9):e75091. doi: 10.1371/journal.pone.0075091. eCollection 2013.

21.

A comparative study of CSF neurofilament light and heavy chain protein in MS.

Kuhle J, Plattner K, Bestwick JP, Lindberg RL, Ramagopalan SV, Norgren N, Nissim A, Malaspina A, Leppert D, Giovannoni G, Kappos L.

Mult Scler. 2013 Oct;19(12):1597-603. doi: 10.1177/1352458513482374. Epub 2013 Mar 25.

PMID:
23529999
22.

Allele specific expression of the transthyretin gene in swedish patients with hereditary transthyretin amyloidosis (ATTR V30M) is similar between the two alleles.

Norgren N, Hellman U, Ericzon BG, Olsson M, Suhr OB.

PLoS One. 2012;7(11):e49981. doi: 10.1371/journal.pone.0049981. Epub 2012 Nov 19.

23.

A high-penetrance form of late-onset torsion dystonia maps to a novel locus (DYT21) on chromosome 2q14.3-q21.3.

Norgren N, Mattson E, Forsgren L, Holmberg M.

Neurogenetics. 2011 May;12(2):137-43. doi: 10.1007/s10048-011-0274-9. Epub 2011 Feb 8.

PMID:
21301909
24.

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.

Gunnarsson M, Malmeström C, Axelsson M, Sundström P, Dahle C, Vrethem M, Olsson T, Piehl F, Norgren N, Rosengren L, Svenningsson A, Lycke J.

Ann Neurol. 2011 Jan;69(1):83-9. doi: 10.1002/ana.22247. Epub 2010 Dec 8.

PMID:
21280078
25.

A possible role for miRNA silencing in disease phenotype variation in Swedish transthyretin V30M carriers.

Olsson M, Norgren N, Obayashi K, Plante-Bordeneuve V, Suhr OB, Cederquist K, Jonasson J.

BMC Med Genet. 2010 Sep 14;11:130. doi: 10.1186/1471-2350-11-130.

26.

Neurofilament ELISA validation.

Petzold A, Altintas A, Andreoni L, Bartos A, Berthele A, Blankenstein MA, Buee L, Castellazzi M, Cepok S, Comabella M, Constantinescu CS, Deisenhammer F, Deniz G, Erten G, Espiño M, Fainardi E, Franciotta D, Freedman MS, Giedraitis V, Gilhus NE, Giovannoni G, Glabinski A, Grieb P, Hartung HP, Hemmer B, Herukka SK, Hintzen R, Ingelsson M, Jackson S, Jacobsen S, Jafari N, Jalosinski M, Jarius S, Kapaki E, Kieseier BC, Koel-Simmelink MJ, Kornhuber J, Kuhle J, Kurzepa J, Lalive PH, Lannfelt L, Lehmensiek V, Lewczuk P, Livrea P, Marnetto F, Martino D, Menge T, Norgren N, Papuć E, Paraskevas GP, Pirttilä T, Rajda C, Rejdak K, Ricny J, Ripova D, Rosengren L, Ruggieri M, Schraen S, Shaw G, Sindic C, Siva A, Stigbrand T, Stonebridge I, Topcular B, Trojano M, Tumani H, Twaalfhoven HA, Vécsei L, Van Pesch V, Vanderstichele H, Vedeler C, Verbeek MM, Villar LM, Weissert R, Wildemann B, Yang C, Yao K, Teunissen CE.

J Immunol Methods. 2010 Jan 31;352(1-2):23-31. doi: 10.1016/j.jim.2009.09.014. Epub 2009 Oct 24.

PMID:
19857497
27.

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.

Teunissen CE, Iacobaeus E, Khademi M, Brundin L, Norgren N, Koel-Simmelink MJ, Schepens M, Bouwman F, Twaalfhoven HA, Blom HJ, Jakobs C, Dijkstra CD.

Neurology. 2009 Apr 14;72(15):1322-9. doi: 10.1212/WNL.0b013e3181a0fe3f.

PMID:
19365053
28.

CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls.

Pijnenburg YA, Janssen JC, Schoonenboom NS, Petzold A, Mulder C, Stigbrand T, Norgren N, Heijst H, Hack CE, Scheltens P, Teunissen CE.

Dement Geriatr Cogn Disord. 2007;23(4):225-30. Epub 2007 Feb 9.

PMID:
17290105
29.

Optimizing the generation of recombinant single-chain antibodies against placental alkaline phosphatase.

Sheikholvaezin A, Sandström P, Eriksson D, Norgren N, Riklund K, Stigbrand T.

Hybridoma (Larchmt). 2006 Aug;25(4):181-92.

PMID:
16934014
30.

Cerebrospinal fluid levels of neurofilament light in chronic experimental autoimmune encephalomyelitis.

Norgren N, Edelstam A, Stigbrand T.

Brain Res Bull. 2005 Oct 30;67(4):264-8.

PMID:
16182933
31.

Neurofilament and glial fibrillary acidic protein in multiple sclerosis.

Norgren N, Sundström P, Svenningsson A, Rosengren L, Stigbrand T, Gunnarsson M.

Neurology. 2004 Nov 9;63(9):1586-90.

PMID:
15534240
32.

Elevated neurofilament levels in neurological diseases.

Norgren N, Rosengren L, Stigbrand T.

Brain Res. 2003 Oct 10;987(1):25-31.

PMID:
14499942
33.

Monoclonal antibodies selective for low molecular weight neurofilaments.

Norgren N, Karlsson JE, Rosengren L, Stigbrand T.

Hybrid Hybridomics. 2002 Feb;21(1):53-9.

PMID:
11991817

Supplemental Content

Loading ...
Support Center